Analyst Ranking
Top 13%
#638 out of 5001 analysts
Average Return
+8.46%
Win Rate
55%66 out of 119
Risk vs Reward
Poor
Good

Catherine Schulte's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Nanostring Technologies IncNSTGQ
+172.99%$25.14$68.63
2020-04-06 -
2021-04-07
Buy
Exact Sciences CorpEXAS
+117.49%$44.37$96.50
2018-02-26 -
2019-02-27
Buy
Castle Biosciences IncCSTL
+112.13%$28.27$59.97
2020-03-26 -
2021-03-26
Buy
Nanostring Technologies IncNSTGQ
+106.07%$14.00$28.85
2018-06-03 -
2019-06-04
Buy
Nanostring Technologies IncNSTGQ
+96.15%$7.79$15.28
2017-11-02 -
2018-11-02
Buy

Catherine Schulte Analyst Color

Get additional color on Catherine Schulte's coverage of popular stocks

Catherine Schulte's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Agilent Technologies IncA
18Buy$142.00+13.00%Maintains
3 days ago
Mettler Toledo International IncMTD
10Hold$1,230.00-5.46%Maintains
a month ago
Avantor IncAVTR
13Buy$15.00+11.36%Maintains
a month ago
Thermo Fisher Scientific IncTMO
25Buy$567.00+15.08%Maintains
a month ago
Danaher CorpDHR
11Buy$229.00+11.26%Maintains
a month ago
Maravai Lifesciences Holdings IncMRVI
6Hold$2.00-17.36%Maintains
4 months ago
Exact Sciences CorpEXAS
12Buy$72.00+51.83%Maintains
4 months ago
Qiagen NvQGEN
4Hold$43.00-7.53%Maintains
4 months ago
Bio Techne CorpTECH
11Hold$68.00+24.47%Downgrades
6 months ago
Revvity IncRVTY
5Buy$165.00N/AMaintains
2 years ago
Castle Biosciences IncCSTL
4Buy$38.00N/AMaintains
2 years ago
Twist Bioscience CorpTWST
2Buy$33.00N/AMaintains
3 years ago
Biora Therapeutics IncBIOR
1Hold$2.00N/ADowngrades
4 years ago
Chembio Diagnostics IncCEMI
1Buy$21.00N/AInitiates Coverage On
5 years ago
Illumina IncILMN
4Hold$310.00N/ADowngrades
5 years ago
Nanostring Technologies IncNSTGQ
5Buy$29.00N/AMaintains
5 years ago
Waters CorpWAT
5Hold$211.00N/ADowngrades
7 years ago
Natera IncNTRA
1Buy$20.00N/AMaintains
7 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.